The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 25, 2017

Filed:

Aug. 29, 2014
Applicants:

Baxter International Inc., Deerfield, IL (US);

Baxter Healthcare S.a., Glattpark (Opfikon), CH;

Inventors:

Alp Akonur, Evanston, IL (US);

John Kenneth Leypoldt, Libertyville, IL (US);

Ying-Cheng Lo, Green Oaks, IL (US);

Baris Ugur Agar, Chicago, IL (US);

Assignees:

Baxter International Inc., Deerfield, IL (US);

Baxter Healthcare SA, Glattpark (Opfikon), CH;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61M 1/16 (2006.01); A61M 1/36 (2006.01); G06F 19/00 (2011.01);
U.S. Cl.
CPC ...
A61M 1/1603 (2014.02); A61M 1/16 (2013.01); A61M 1/1611 (2014.02); A61M 1/1613 (2014.02); A61M 1/3609 (2014.02); G06F 19/3481 (2013.01);
Abstract

A renal failure blood therapy system includes a renal failure blood therapy machine, a test including multiple blood samples taken at multiple times during a test therapy to determine concentration levels for each of a first solute and a second solute at each of the multiple times, and a device programmed to (i) estimate at least one first patient parameter using the determined concentration levels for the first solute, (ii) estimate at least one second patient parameter using the determined concentration levels for the second solute, (iii) determine a first plurality of acceptable treatments using the at least one first patient parameter, (iv) determine a second plurality of acceptable treatments using the at least one second patient parameter, and (v) merge the first plurality of acceptable treatments with the second plurality of acceptable treatments to determine a plurality of clinically acceptable treatments for both the first solute and the second solute.


Find Patent Forward Citations

Loading…